Research Diagnosis Related Groups (DRG) level LOS quality outcomes for AllianceHealth Midwest located at 2825 Parklawn Dr, Midwest City, OK, 73110 & includes data from NPIs 1093169377, 1043805732, 1730128836, 1417998691, 1700471497
Dexur analyzed Q3 2019 (July to September 2019) Medicare claims data to benchmark length of stay (LOS) outcomes for AllianceHealth Midwest compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 634 | 581 | ||||||||||
Surgical | 102 | 99 | ||||||||||
Non Surgical | 532 | 482 | ||||||||||
Psychiatry & Mental Disorders | 119 | 110 | ||||||||||
Cardiovascular | 101 | 93 | ||||||||||
General Medicine | 100 | 86 | ||||||||||
Gastroenterology & Endocrinology | 64 | 63 | ||||||||||
Orthopedics | 59 | 55 | ||||||||||
Pulmonology | 57 | 51 | ||||||||||
Urology | 45 | 41 | ||||||||||
Neurology | 36 | 33 | ||||||||||
General Surgery | 23 | 21 | ||||||||||
Oncology & Hematology | 16 | 15 |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||
DRG 885: PSYCHOSES |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I.Hemorrhage |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Chronic Obstructive Pulmonary Disease |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2019 to Sep 2019) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |